Michael Witten is a science advisor and registered patent agent in Goodwin’s Life Sciences group. Dr. Witten is a trained synthetic organic chemist with research experience in medicinal chemistry and catalysis. He joined Goodwin in 2025.
PROFESSIONAL EXPERIENCE
Dr. Witten earned a Ph.D. from Harvard University, where he performed research on asymmetric organocatalysis in the laboratory of Eric Jacobsen. Prior to joining Goodwin, Michael was a postdoctoral fellow at Yale University, studying medicinal chemistry and transition metal catalysis under Jonathan Ellman. Most recently, he worked as a medicinal chemist at a pharmaceutical company where he contributed as an inventor on several patents.
Credentials
Education
PhD2015
Harvard University
AM2011
Harvard University
BS2009
New York University
Admissions
Courts
- U.S. Patent and Trademark Office
Recognition & Awards
Ruth L. Kirschstein National Research Service Award (NIH) Individual Postdoctoral Fellowship, 2015
National Defense Science and Engineering Graduate Fellowship, 2010